Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-29.39M.
ENTERPRISE VALUE (EV)
$-29.39M
Incannex Healthcare Limited
Market Cap
$38.23M
Enterprise Value (EV)
$-29.39M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Incannex Healthcare Limited (IXHL) | $38.23M | $-29.39M |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.97M | $76.67M |
| Edesa Biotech, Inc. (EDSA)vs › | $37.28M | $26.95M |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | $27.28M |
| Nephros, Inc. (NEPH)vs › | $39.90M | $36.07M |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | $38.97M |
| DocGo Inc. (DCGO)vs › | $36.05M | $36.73M |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | $28.27M |
| Elutia Inc (ELUT)vs › | $34.84M | $25.73M |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.74M | N/A |
Market Cap
$38.23M
Total Debt
$96000.00
Cash
$67.71M
Enterprise Value
$-29.39M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
